These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30285655)

  • 1. Long-term survival in Japanese renal transplant recipients with Alport syndrome: a retrospective study.
    Katsuma A; Nakada Y; Yamamoto I; Horita S; Furusawa M; Unagami K; Katsumata H; Okumi M; Ishida H; Yokoo T; Tanabe K;
    BMC Nephrol; 2018 Oct; 19(1):249. PubMed ID: 30285655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies.
    Kalluri R; Torre A; Shield CF; Zamborsky ED; Werner MC; Suchin E; Wolf G; Helmchen UM; van den Heuvel LP; Grossman R; Aradhye S; Neilson EG
    Transplantation; 2000 Feb; 69(4):679-83. PubMed ID: 10708133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of kidney transplantation in Alport syndrome compared with other forms of renal disease.
    Kelly YP; Patil A; Wallis L; Murray S; Kant S; Kaballo MA; Casserly L; Doyle B; Dorman A; O'Kelly P; Conlon PJ
    Ren Fail; 2017 Nov; 39(1):290-293. PubMed ID: 27917694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.
    Hudson BG; Kalluri R; Gunwar S; Weber M; Ballester F; Hudson JK; Noelken ME; Sarras M; Richardson WR; Saus J
    Kidney Int; 1992 Jul; 42(1):179-87. PubMed ID: 1635348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
    Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of alpha5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome.
    Nakanishi K; Iijima K; Kuroda N; Inoue Y; Sado Y; Nakamura H; Yoshikawa N
    J Am Soc Nephrol; 1998 Aug; 9(8):1433-40. PubMed ID: 9697665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of glomerular type IV collagen alpha3-5 chain expression in children with thin basement membrane disease.
    Ueda T; Nakajima M; Akazawa H; Maruhashi Y; Shimoyama H; Sakagami Y; Takagawa K; Kamitsuji H; Naito I; Sado Y; Yoshioka A
    Nephron; 2002 Oct; 92(2):271-8. PubMed ID: 12218303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of alpha-chains of type IV collagen in glomerular basement membranes with ultrastructural alterations suggestive of Alport syndrome.
    Barsotti P; Muda AO; Mazzucco G; Massella L; Basolo B; De Marchi M; Rizzoni G; Monga G; Faraggiana T
    Nephrol Dial Transplant; 2001 May; 16(5):945-52. PubMed ID: 11328899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
    Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
    J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked Alport syndrome in females.
    Meleg-Smith S; Magliato S; Cheles M; Garola RE; Kashtan CE
    Hum Pathol; 1998 Apr; 29(4):404-8. PubMed ID: 9563792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
    Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
    J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
    Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
    J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target.
    vd Heuvel LP; Schröder CH; Savage CO; Menzel D; Assmann KJ; Monnens LA; Veerkamp JH
    Pediatr Nephrol; 1989 Oct; 3(4):406-13. PubMed ID: 2642109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
    Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
    Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Alport nephropathy: clinicopathological correlations.
    White RH; Raafat F; Milford DV; Komianou F; Moghal NE
    Pediatr Nephrol; 2005 Jul; 20(7):897-903. PubMed ID: 15856312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living related kidney transplantation in a patient with autosomal-recessive Alport syndrome.
    Sakai K; Muramatsu M; Ogiwara H; Kawamura T; Arai K; Aikawa A; Ohara T; Mizuiri S; Joh K; Naito I; Hasegawa A
    Clin Transplant; 2003; 17 Suppl 10():4-8. PubMed ID: 12823249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology, ultrastructure, and clinical phenotypes in thin glomerular basement membrane disease variants.
    Liapis H; Gökden N; Hmiel P; Miner JH
    Hum Pathol; 2002 Aug; 33(8):836-45. PubMed ID: 12203217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
    Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
    Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.
    Cosgrove D; Liu S
    Matrix Biol; 2017 Jan; 57-58():45-54. PubMed ID: 27576055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.